🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

A most welcome new CAR-T construct. Congratulations ⁦Claire Roddie⁩ et al. ⁦NEJM⁩ ⁦IACH⁩

Which version do you like most? Ahaha #ASH24 this is awesome!!!

I'm concerned that the recent STAT piece re: decline of #BMT by Angus Rohan Chen could be misleading to the public. Adding some context for consideration in the thread 🧵below: statnews.com/2024/12/24/bon…

Happy to share our work published in Nature Medicine! We analyzed 3,066 patients from the French DESCAR-T registry who received #CARTcell therapy. Our findings indicate a very low risk of T-cell malignancy after CAR T-cell therapy: only 1 case (0.03%). nature.com/articles/s4159…

The power of transplantation to reverse-engineer a so-called "chronic" disease An educational thread on myelofibrosis and a bow for my mentor nejm.org/doi/full/10.10…

👉🏼👉🏼Excited to see this practical guide online: Clinical genomic profiling of MDS to inform allo-HCT decisions🔔. Thanks to all international co-authors and in particular Carmelo Gurnari for driving this forward! The EBMT SBTMO Anna Sureda The EBMT Trainee Committee Ibrahim Yakoub-Agha

A MUST-READ!!!

Despite efforts to understand, we still do not know how to use it. A survey-review of the current landscape of immune monitoring procedures in CAR-T cell therapies across EBMT-affiliated centers. 👇EBMT_Cellular_Therapy Annalisa Ruggeri Jurgen Kuball Christian Chabannon sciencedirect.com/science/articl…

We are excited to present all the confirmed speakers for our IV #MultiregionalSBTMO Meeting! 📅 March 21-22 | 100% online 🔗Register now: multirregionalsbtmo.org.br Don't miss the opportunity to expand your knowledge, enhance your practice, and grow your professional network!

Join our IV SBTMO meeting on prevention & treatment of relapse after HCT! 100% virtual! 🙏to the chairs, moderators & all speakers Javier Bolaños Meade, MD DrDonalMcLornan Corey Cutler Kris Mahadeo Luciano J Costa Meral Beksac Nico Gagelmann hamer Adriana Seber Simona Pagliuca Lucila Kerbauy

🔎 Have you seen this recent article? 📰 The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT⬇️ pubmed.ncbi.nlm.nih.gov/39986989/ Authors 👥 Simona Pagliuca, Florent Malard,

Another piece of the puzzle of IAA physiopathology. Brillant work led by Sofie Lundgren & Jani Huuhtanen from Mustjokilab

A machine learning approach for the rapid identification of measurable residual disease in acute myeloid leukemia haematologica.org/article/downlo…

B-cell maturation antigen–directed CAR-T therapy in patients with MM and CNS involvement is feasible without excess neurotoxicity. ow.ly/gHp450VgqF9 #plasmacelldisorders

Very honored to share The EBMT recommendations for the management and #alloHCT of atypical #MDSMPN and #MPN, just published in @BloodJournal 👉doi.org/10.1182/blood.… Many thanks to all the authors for this great result! DrDonalMcLornan Nico Gagelmann Katja Sockel Naveen Pemmaraju, MD

T Cell LPDs Hopefully this chart will make your life Easier😀 #hematology #meded #medtwitter #medicine #blooducation

AMAZING TALK, Simona Pagliuca The EBMT as always !!! Leukemia relapse via genetic immune escape after allogeneic HCT! There is so much to learn! ❤️❤️🔝🔝🔝SBTMO 4th annual relapse meeting !

Relapse after HSCT meeting #SBTMO #MPN Nico Gagelmann Nikolaus Kroeger , Fernando Barroso, Nelson Hamerschlak . Great session. SBTMO

Excited to see our NIH NHLBI work just published in Blood Advances showing the negative effects of HLA alloimmunization in #SAA patients treated with immunosuppression. Lead by our former fellow Jibran Durrani now UMiami Health System Bhavisha Patel Neal S Young M.D. ashpublications.org/bloodadvances/…

🥰🥰🥰🥰🔝🔝🔝🔝🔝SBTMO LABMT Young LABMT The EBMT Eurocord Annalisa Ruggeri Krzysztof Kałwak CTC USP 🇧🇷🇧🇷🇧🇷